Medicare Wegovy prescriptions soar following heart disease approval
Following a pivotal FDA expansion approving the weight-loss drug Wegovy (semaglutide) to reduce cardiovascular risk, Medicare has experienced a dramatic ...
Following a pivotal FDA expansion approving the weight-loss drug Wegovy (semaglutide) to reduce cardiovascular risk, Medicare has experienced a dramatic ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine